Report
EUR 13.66 For Business Accounts Only

By reducing its risk exposure, AS ONE improves to Slightly Positive

AS ONE (JP), a company active in Medical Equipment, reduces its risk exposure and improves its general evaluation despite the loss of a fundamental star(s). The independent financial analyst theScreener has removed a fundamental star(s) of the title, which now shows 2 out of 4 stars; conversely, its market risk is now considered lower and can be described as defensive. Despite the loss of a star, theScreener upgrades the general evaluation of the title to Slightly Positive. As of the analysis date April 5, 2022, the closing price was JPY 7,320.00 and its potential was estimated at JPY 8,115.59.
Underlying
As One Corp.

As One is mainly engaged in the wholesale of scientific equipment and apparatuses. Along with its subsidiaries, Co. operates in two business divisions: research and industrial equipment, and hospital and nursing care. Co. is involved in the wholesale of equipment and apparatuses used by researchers and technicians to scientific equipment dealers, the provision of product catalogs to dealers including the import and sale of laboratory apparatuses; and the wholesale of equipment and apparatuses used by nurses and nursing care professionals to medical and nursing care institutions.

Provider
TheScreener
TheScreener

Empowering Investors

theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals.  Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.

  • Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization.  theScreener state of art: We provide
  • theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
  • For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded

 

Other Reports on these Companies
Other Reports from TheScreener

ResearchPool Subscriptions

Get the most out of your insights

Get in touch